Barclays, Illumina
1d
Zacks Investment Research on MSNHere's Why Illumina (ILMN) is a Strong Growth StockTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday. The company posted quarterly ...
The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...
The damage to Illumina's stock will depend whether it continues to be included on that rather vague blacklist. And, further into the future, how the broader U.S.-China fight develops -- given the ...
Illumina Inc. closed 21.61% short of its 52-week high of $156.66, which the company reached on November 5th.
Illumina Inc., based in San Diego, provides sequencing and array-based solutions for genetic analysis. The company's products and services are sold to genomic research centers, academic institutions ...
and streamline your search for investment opportunities using Tipranks' Stock Screener Patrick B Donnelly has given his Hold rating due to a combination of factors impacting Illumina’s financial ...
Wall Street analysts forecast that Illumina (ILMN) will report quarterly ... This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results